Paricalcitol is a drug used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure.
It is still in R&D stage.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Paricalcitol</strong> is a synthetic vitamin D2 analog used primarily in pharmaceutical manufacturing. Produced via specialized chemical synthesis, its molecular formula is <strong>C27H44O3</strong> and CAS number is <strong>128069-56-7</strong>.</p>
<h3>Application</h3>
<ul>
<li>Treatment of secondary hyperparathyroidism in chronic kidney disease patients.</li>
<li>Management of calcium metabolism disorders in dialysis populations.</li>
<li>Research applications for bone mineral density studies.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly monitor serum calcium levels to prevent hypercalcemia. Store in a cool, dry place away from direct light. Handle with appropriate PPE due to potent biological activity.</p>